CK Life Sciences International (Holdings), Inc. released its earnings results on Mar 18, 2025. The company reported -HK$0.013 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.013.

Is CK Life Sciences International (Holdings), Inc. overvalued?

According to Wall Street analysts CK Life Sciences International (Holdings), Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does CK Life Sciences International (Holdings), Inc. pay dividends?

CK Life Sciences International (Holdings), Inc. pays a Annually dividend of HK$0.008 which represents an annual dividend yield of N/A. See more information on CK Life Sciences International (Holdings), Inc. dividends here

What is CK Life Sciences International (Holdings), Inc.’s EPS estimate?

CK Life Sciences International (Holdings), Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does CK Life Sciences International (Holdings), Inc. have?

CK Life Sciences International (Holdings), Inc. has 9,611,072,000 shares outstanding.

What happened to CK Life Sciences International (Holdings), Inc.’s price movement after its last earnings report?

CK Life Sciences International (Holdings), Inc. reported an EPS of -HK$0.013 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.263%.

Which hedge fund is a major shareholder of CK Life Sciences International (Holdings), Inc.?

Currently, no hedge funds are holding shares in HK:0775

---

CK Life Sciences International (Holdings), Inc. Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

-3.29%

Trailing 12-Months

Asset Growth

-4.08%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

CK Life Sciences International (Holdings), Inc.

CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products. In addition, it distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; produces, refines, and distributes salt products; and provides research and development services for biotechnology and life sciences technology products. Further, it researches, develops, manufactures, and commercializes drug products to treat pain and melanoma; supplies raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food segments; and offers packing and asset management services. CK Life Sciences Int'l., (Holdings) Inc. was founded in 1999 and is headquartered in Tai Po, Hong Kong.

---